1. Home
  2. CKX vs ITRM Comparison

CKX vs ITRM Comparison

Compare CKX & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$10.31

Market Cap

22.3M

Sector

Energy

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CKX
ITRM
Founded
1930
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
24.3M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
CKX
ITRM
Price
$10.31
$0.03
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
15.0K
30.9M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1125.00
57.43
EPS
0.03
N/A
Revenue
$838,543.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
$373.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$0.03
52 Week High
$13.25
$1.16

Technical Indicators

Market Signals
Indicator
CKX
ITRM
Relative Strength Index (RSI) 44.41 26.10
Support Level $10.21 N/A
Resistance Level $10.78 $0.39
Average True Range (ATR) 0.48 0.02
MACD -0.06 -0.01
Stochastic Oscillator 7.95 3.34

Price Performance

Historical Comparison
CKX
ITRM

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: